CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patientโs EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patientโs EEG data.
๋์ ์ฑ์ฅ
ํ์ฌ์ ๋งค์ถ์ ์ง๋ 3๋
๊ฐ ๊พธ์คํ ์ฑ์ฅํด์์ผ๋ฉฐ, ์ฐํ๊ท 96.93%์ ์ฆ๊ฐ์จ์ ๊ธฐ๋กํ์ต๋๋ค.
์ฑ์ฅ ์ค
ํ์ฌ๋ ์ฑ์ฅ ๋จ๊ณ์ ์์ผ๋ฉฐ, ์ต์ ์ฐ๊ฐ ์์ต์ ๋ฏธํ 89.06M์ ๋ฌํฉ๋๋ค.
๊ณ ์์ต ์ฑ์ฅ
ํ์ฌ์ ์์ด์ต์ ์
๊ณ ์ ๋๋ฅผ ๋ฌ๋ฆฌ๊ณ ์์ผ๋ฉฐ, ์ต๊ทผ ์ฐ๊ฐ ์์ด์ต์ ๋ฏธํ 89.06M์ ๋ฌํฉ๋๋ค.
๊ณต์ ํ ๊ฐ์น
ํ์ฌ์ ์ต์ PE์ -12.00๋ก, ์ต๊ทผ 3๋
๊ธฐ์ค ์ค๊ฐ ๋ฐฑ๋ถ์ ๋ฒ์์ ์ํฉ๋๋ค.
๊ธฐ๊ด ๋งค๋
์ต์ ๊ธฐ๊ด ๋ณด์ ์ฃผ์ ์๋ 31.90M์ฃผ์ด๋ฉฐ, ์ ๋ถ๊ธฐ ๋๋น 4.88% ๊ฐ์ํ์ต๋๋ค.
์ฒ ๋ก์ด์ค๊ฐ ๋ณด์
์คํ ํฌ์์ ์ฒ ๋ก์ด์ค์ด(๊ฐ) ์ด ์ฃผ์ 505.35K์ฃผ๋ฅผ ๋ณด์ ํ๊ณ ์์ต๋๋ค.